直觉外科公司是一家医疗器械公司,主要生产机器人辅助手术系统。10月18日,公司股价盘中大涨10.43%,报收512.21美元,引发了市场的广泛关注。
股价大涨主要源于公司当季业绩表现优异。数据显示,公司第三季度营收达20.4亿美元,同比增长17%,超过市场预期的20亿美元。调整后每股收益为1.84美元,也高于分析师预期的1.63美元。这主要得益于公司旗舰产品达芬奇手术机器人的需求强劲,该机器人在第三季度完成的手术量同比大涨18%。
分析人士普遍看好直觉外科业绩表现和长期前景。杰富瑞预计机器人辅助手术在未来将持续增长,并逐步取代传统手术方式。利明马汀认为直觉外科高利润率将使其股价持续高于同行。RBC资本市场则预计到2026年,全球达芬奇手术量将实现中位数增长。此外,消息人士认为中国市场对直觉外科新产品需求强劲,也将进一步支撑其业绩增长。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.